Role of Baseline and Post-Therapy 18F-FDG PET in the Prognostic Stratification of Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated with Radium-223

Radium-223 dichloride (Ra223) represents the unique bone-directed treatment option that shows an improvement in overall survival (OS) in metastatic castrate resistant prostate cancer (mCRPC). However, there is an urgent need for the identification of reliable biomarkers to non-invasively determine i...

Descripción completa

Detalles Bibliográficos
Autores principales: Bauckneht, Matteo, Capitanio, Selene, Donegani, Maria Isabella, Zanardi, Elisa, Miceli, Alberto, Murialdo, Roberto, Raffa, Stefano, Tomasello, Laura, Vitti, Martina, Cavo, Alessia, Catalano, Fabio, Mencoboni, Manlio, Ceppi, Marcello, Marini, Cecilia, Fornarini, Giuseppe, Boccardo, Francesco, Sambuceti, Gianmario, Morbelli, Silvia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016706/
https://www.ncbi.nlm.nih.gov/pubmed/31861942
http://dx.doi.org/10.3390/cancers12010031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016706/
https://www.ncbi.nlm.nih.gov/pubmed/31861942
http://dx.doi.org/10.3390/cancers12010031

Ejemplares similares